期刊文献+

心脏肌球蛋白结合蛋白C基因S236G新突变致肥厚型心肌病表型研究 被引量:3

A novel hot-spot mutation S236G in the cardiac myosin binding protein C gene in Chinese patient with hypertrophic cardiomyopathy
原文传递
导出
摘要 目的研究中国人肥厚型心肌病的致病基因突变位点,寻找国人特有的热点突变并分析基因型与临床表型的相互关系。方法在100例肥厚型心肌病患者以及120名健康对照者中进行心脏型肌球蛋白结合蛋白C(Mx/BPC3)基因突变筛查,聚合酶链式反应(PCR)扩增基因功能区外显子片段并对PCR产物进行测序分析。结果在3例肥厚型心肌病患者中发现MYBPC3基因第6号外显子第706位碱基由T转换为C,结果导致第236位的丝氨酸(Ser,S)转变为甘氨酸(Gly,G),正常对照组相同位置未发现异常。该突变在西方人中未见报道,携带该突变的肥厚型心肌病患者呈现不同的临床表型。结论首次在中国人肥厚型心肌病患者中发现MYBPC3基因S236G突变,其在中国人肥厚型心肌病患者中占有一定的比例,是热点突变之一。 Objective To identify the disease-causing gene mutations and to reveal the relationship between the genotype and the phenotype in Chinese patients with hypertrophic cardiomyopathy ( HCM ). Methods One hundred unrelated patients with HCM and 120 controls were enrolled in this study. The full encoding exons and flanking sequences of the cardiac myosin binding protein C gene ( MYBPC3 ) were amplified with PCR and the products were sequenced. Results A novel missense mutation c. 706T 〉 C was identified in exon 6 of MYBPC3 gene in three HCM patients, which resulted a Serine (S) to Glycine (G) exchange at amino acid residue 236 (S236G). The clinical phenotypes of the three patients were different (2 obstructive HCM, 1 non-obstructive HCM). The 120 controls were normal in the genetic test. Conclusions The novel S236G mutation in MYBPC3 gene was a hot-spot mutation in Chinese patients with HCM.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2009年第12期1078-1080,共3页 Chinese Journal of Cardiology
基金 国家自然科学基金资助项目(30600239) 国际科技合作资助项目(2006DFA31500)
关键词 心肌病 肥厚性 突变 表型 Cardiomyopathy, hypertrophic Mutation Phenotype
  • 相关文献

参考文献12

  • 1Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation, 1996, 93:841-842.
  • 2Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy : the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med,2008, 5:158-168.
  • 3Marian A J, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Am Coil Cardiol, 2001, 33:655- 670.
  • 4Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation, 2003, 107:2227-2232.
  • 5Niimura H, Patton KK, McKenna WJ, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation, 2002, 105:446-451.
  • 6Charron P, Dubourg O, Desnos M, et al. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy: a comparison between mutations in the cardiac protein C and the myosin heavy chain genes. Eur Heart J, 1998, 19:139-145.
  • 7Gruen M, Prinz H, Gautel M. cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett, 1999, 453:254-259.
  • 8Witt CC, Gerull B, Davies MJ, et al. Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C. J Biol Chem, 2001, 276:5353-5359.
  • 9Van Driest SL, Vasile VC, Ommen SR, et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coil Cardiol, 2004, 44:1903-1910.
  • 10Rottbauer W, Gautel M, Zehelein J, et al. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest, 1997, 100:475-482.

同被引文献25

  • 1刘文玲,谢文丽,胡大一,朱天刚,李运田,孙艺红,李翠兰,李蕾,李田昌,边红,仝其广,杨松娜,范瑞云,崔炜.十个汉族家族性肥厚型心肌病MYH7、MYBPC3和TNNT2基因筛查结果及相应的临床特征[J].中华心血管病杂志,2006,34(3):202-207. 被引量:25
  • 2刘秀荣,杨鹏,曹正新,王艳,周春霞,宋雨,张爱娟,李云.原发性高血压患者血管紧张素转换酶基因多态性与左室肥厚的相关性研究[J].临床荟萃,2006,21(19):1379-1382. 被引量:5
  • 3王曙霞,邹玉宝,傅春燕,王虎,王继征,宋晓东,陈敬洲,惠汝太.心脏型肌球蛋白结合蛋白C基因13261 G>A突变导致肥厚型心肌病的临床表型分析[J].中华心血管病杂志,2007,35(1):17-20. 被引量:5
  • 4Sun JC, Lanier LL. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunily [ J]. Eur J lmmunol, 2009, 39 ( 8 ) : 2059 - 2064.
  • 5Farag SS, Fehniger TA, Ruggeri L, et al. Natural killer cell recep- tors: new biology and insights into the graft-versus-leukemia effect [J]. Blood, 2002, 100(6) : 1935 - 1947.
  • 6Castriconi R, Dondero A, Cilli M, et al. Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice[ J]. Cancer lmmunol Immunother, 2007, 56 ( 11 ) : 1733 - 1742.
  • 7Cho D, Campana D. Expansion and activation of natural killer cells for cancer immunotherapy[ J]. Korean J Lab Med, 2009, 29( 2 ) : 89 - 96.
  • 8Lassen MG, Lukens JR, Dolina JS, et al. lntrahepatic IL-10 main- rains NKG2A + Ly49- liver NK ceils in a functionally hyporesponsive state[J]. Jlmmunol, 2010, 184(5): 2693 -2701.
  • 9Ho EL, Carayannopoulos LN, Poursine-l,aurent .I, et al. Costimula- tion of multiple NK cell acti,Jation reeeptors by NKG2D[J]. J Immu- nol, 2002, 169(7) : 3667 -3675.
  • 10Diefenbach A, Jensen ER, Jamieson AM, et al. Rael and H60 lig- ands of the NKG2D receptor stimulate tumour immunity[ J]. Nature, 2001, 413(6852) : 165 -171.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部